Aplicabilidad de las pruebas de esfuerzo en neumología

Archivos de Bronconeumologia

Volumn 36, Issue 1, 2000, Pages 44-51

  Ribas, J ^a,b  

^a Hospital Residencia Sant Camil   (Spain)

^b Fundació Hospital Residència Sant Camil   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CONTRAINDICATION; EXERCISE TEST; EXERCISE TOLERANCE; HUMAN; LUNG DISEASE; LUNG FUNCTION TEST; METHODOLOGY; PATHOPHYSIOLOGY; REVIEW;

EXERCISE TEST; EXERCISE TOLERANCE; HUMANS; LUNG DISEASES; RESPIRATORY FUNCTION TESTS;

EID: 0346041722     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2896(15)30232-5     Document Type: Review

References (70)

1. a ed.). Filadelfia: Lea & Febiger, 1994.
2. Whipp BJ. The bioenergetic and gas exchange basis of exercise testing. Clin Chest Med 1994; 15: 173-192.
3. Jones NL, Makrides L, Hitchcock C, Chypchar T, McCartney N. Normal standards for an incremental progressive cycle ergometer test. Am Rev Respir Dis 1985; 131: 700-708.
4. Hansen JE, Sue DY, Wasserman K. Predicted values for clinical exercise testing. Am Rev Respir Dis 1984; 129: 549-555.
5. Blackie SP, Fairbarn MS, McElvaney NG, Morrison NJ, Wilcox PG, Pardy RL. Prediction of maximal oxygen uptake and power during cycle ergometry in subjects older than 55 years of age. Am Rev Respir Dis 1989; 139: 1424-1429.
6. Hermansen L, Saltin B. Oxygen uptake during maximal treadmill and bicycle exercise. J Appl Physiol 1969; 26: 1-31.
7. Zeballos RJ, Weisman IM. Behind the scenes of cardiopulmonary exercise testing. Clin Chest Med 1994; 15: 193-213.
8. Casaburi R, Prefaut C, Cotes JE. Equipment, measurements and quality control in clinical exercise testing. Eur Respir Mon 1997; 6: 72-87.
9. Roca J, Weisman I, Palange P, Whipp BJ. Guidelines for interpretation. Eur Respir Mon 1997; 6: 88-114.
10. Folgering H, Palange P, Anderson S. Clinical exercise testing with reference to lung diseases: indications and protocols. Eur Respir Mon 1997; 6: 51-71.
11. Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJM. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992; 146: 935-940.
12. Agustí AGN, Barberá JA, Roca J, Wagner PD, Guitart R, Rodríguez-Roisín R. Hypoxic pulmonary vasoconstriction and gas exchange during exercise in chronic obstructive pulmonary disease. Chest 1990; 97: 268-275.
13. Dantzker DR, D'Alonzo GE. The effect of exercise on pulmonary gas exchange in patients with severe chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 134: 1.135-1.139.
14. Paintal AS. Vagal sensory receptors and their reflex effects. Physiol Rev 1973; 53: 159-227.
15. Agustí AGN, Cotes J, Wagner PD. Responses to exercise in lung diseases. Eur Respir Mon 1997; 6: 32-50.
16. Marciniuk DD, Gallagher CG. Clinical exercise testing in interstitial lung disease. Clin Chest Med 1994; 15: 287-303.
17. Agusti AGN, Roca J, Gea J, Wagner PD, Xaubet A, Rodrígez-Roisín R. Mechanisms of gas-exchange impairment in idiopatic pulmonary fibrosis. Am Rev Respir Dis 1991; 143: 219-225.
18. Agustí AGN. Roca J, Rodríguez-Roisín R, Xaubct A. Agustí-Vidal A. Different patterns of gas exchange response to exercise in asbestosis and idiopathic pulmonary fibrosis. Eur Respir J 1988; 1: 510-516.
19. Miller A, Brown LK, Sloane MF, Bhuptani A, Teirstein AS. Cardiorespiratory responses to incremental exercise in sarcoidosis patients with normal spirometry. Chest 1995; 107: 323-329.
20. Dantzker DR, D'Alonzo GE, Bower JS, Popat K, Crevey BJ. Pulmonary gas exchange during exercise in patients with chronic obliterative pulmonary hypertension. Am Rev Respir Dis 1984; 130: 412-416.
21. Curtis JR, Deyo RA, Hudson LD Health-related quality of life among patients with chronic obstructive pulmonary disease. Thorax 1994; 49: 162-170.
22. Weisman IM, Zeballos J. An integrated approach to the interpretation of cardiopulmonary exercise testing. Clin Chest Med 1994; 15: 421-445.
23. Eschenbacher WL, Mannina A. An algorithm for the interpretation of cardiopulmonary exercise tests. Chest 1990; 97: 263-267.
24. Messner-Pellenc P, Ximencs C, Brasileiro CF, Mercier J, Grolleau R, Préfaut CG. Cardiopulmonary exercise testing. Determinants of dyspnea dure to cardiac or pulmonary limitation. Chest 1994; 106: 354-360.
25. Weisman IM, Zebalos RJ. Cardiopulmonary exercise testing. Pulmonary Critical Care Update Series 1995; 11: 1-9.
26. Martínez FJ, Stanopoulos I, Acero R, Becker FS, Pickering R, Beamis JF. Graded comprehensive cardiopulmonary exercise testing in the evaluation of dyspnea unexplained by routine evaluation. Chest 1994; 105: 168-174.
27. Nixon PA, Orenstein DM, Kelsey SF, Doershuk CF. The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med 1992; 327: 1785-1788.
28. Rubin LJ. ACCP Consensus Statement. Primary pulmonary hypertension. Chest 1993; 104: 236-250.
29. Rhodes J, Barst RJ, Garofano RP, Thoele DG, Gersony WM. Hemodynamic correlates of exercise function in patients with primary pulmonary hypertension. J Am Coll Cardiol 1991; 18: 1738-1744.
30. Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996; 334: 296-301.
31. Costes JR, Zejda J, King B. Lung function impairment as a guide to exercise limitation in work-related lung disorders. Am Rev Respir Dis 1988; 137: 1089-1093.
32. Ortega F, Montemayor T, Sanchez A, Cabello F, Castillo J. Role of cardiopulmonary exercise testing and the criteria used to determine disability in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 150: 747-751.
33. Sue DY. Exercise testing in the evaluation of impairment and disability. Clin Chest Med 1994; 15: 369-387.
34. American Thoracic Society. Pulmonary rehabilitation. Am Rev Respir Dis 1981; 124: 663-666.
35. Patessio A, Casaburi R, Préfaut C, Folgering H, Donner C. Exercise training in chronic lung disease: exercise prescription. Eur Respir Mon 1997; 6: 129-146.
36. Casaburi R, Patessio A, Ioli F, Zanaboni S, Donner C, Wasserman K. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis 1991; 143: 9-18.
37. Ries AL. The importance of exercise in pulmonary rehabilitation. Clin Chest Med 1994; 15: 327-337.
38. Celli BR. The clinical use of upper extremity exercise. Clin Chest Med 1994; 15: 339-349.
39. Sterk PJ, Fabbri LM, Quanjer PH, Cockcroft DW, O'Byme PM, Anderson SD et al. Airway responsiveness: standardized challenge testing with pharmacological, physical ans sensitizing stimuli in adult. Eur Respir J 1993; 6: 53-83.
40. Haby MM, Peat JK, Mellis CM, Anderson SD, Woolcock AJ. An exercise challenge for epidemiological studies of childhood asthma: validity and repeatability. Eur Respir J 1995; 8: 729-736.
41. Cypcar D, Lemanske RF. Asthma and exercise. Clin Chest Med 1994; 15: 351-368.
42. Estenne M, Higenbottam TW. Exercise response in lung transplantation: assessment and rehabilitation programmes. Eur Respir Mon 1997; 6: 147-157.
43. De Hoyos A, Demajo W, Snell G, Miller J, Winton T, Maurer JR et al. Preoperative prediction for the use of cardiopulmonary bypass in lung transplantation. J Thorac Cardiovasc Surg 1993; 106: 787-796.
44. Howard DK, Iademarco EJ, Trulock EP. The role of cardiopulmonary exercise testing in lung and heart-lung transplantation. Clin Chest Med 1994; 15: 405-420.
45. Sánchez de Cos J. Tratamiento actual del carcinoma broncopulmonar no microcítico y nueva clasificación TNM. Arch Bronconeumol 1999; 35: 94-96.
46. Legge JS, Palmer KNV. Pulmonary function in bronchogenic carcinoma. Thorax 1973; 28: 588-591.
47. Olsen GN, Block AJ, Swenson EW, Castle JR, Wynne JW. Pulmonary function evaluation of the lung resection candidate: a prospective study. Am Rev Respir Dis 1975; 111: 379-387.
48. Smith TP, Kinasewitz GT, Tucker WY, Spillers WP, George RB. Exercise capacity as a predictor of post-thoracotomy morbidity. Am Rev Respir Dis 1984, 129: 730-734.
49. Morice RC, Peters EJ, Ryan MB, Putnam JB, Ali MK, Roth JA. Exercise testing in the evaluation of patients at high risk for complications from lung resection. Chest 1992; 101: 356-361.
50. Walsh GL, Morice RC, Putnam JB, Nesbitt JC, McMurtrey MJ, Ryan MB et al. Resection of lung cancer is justified in high-risk patients selected by exercise oxygen consumption. Ann Thorac Surg 1994; 58: 704-711.
51. Bolliger CT, Wyser C, Roser H, Solèr M, Perruchoud AP. Lung scanning and exercise testing for the prediction of postoperative performance in lung resection candidates at increased risk for complications. Chest 1995; 108: 341-348.
52. Pate P, Tenholder MF, Griffin JP, Eastridge CE, Weiman DS. Preoperative assessment of the high-risk patient for lung resection. Ann Thorac Surg 1996; 61: 1494-1500.
53. Olsen GN, Weiman DS, Bolton JWR, Gass GD, McLain WC, Schoonover GA et al. Submaximal invasive exercise testing and quantitative lung scanning in the evaluation for tolerance of lung resection. Chest 1989; 95: 267-273.
54. Holden DA, Rice TW, Stelmach K, Meeker DP. Exercise testing, 6-min walk, and stair climb in the evaluation of patients at high risk for pulmonary resection. Chest 1992; 102: 1774-1779.
55. Markos J, Mullan BP, Hillman DR, Musk AW, Antico VF, Lovegrove FT et al. Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis 1989; 139: 902-910.
56. Puente L, Rodríguez JL, Ruiz JM, Santa-Crus A, De Lucas P, García J et al. Valor de la estimación de la captación de oxígeno maxima postoperatoria en la predicción de insuficiencia cardiorrespiratoria en el postoperatorio inmediato de cirugía de tórax. Arch Bronconeumol 1998; 34: 127-132.
57. Ribas J, Díaz O, Barberà JA, Mateu M, Canalís E, Jover L et al. Invasive exercise testing in the evaluation of patients at high-risk for lung resection. Eur Respir J 1998; 12: 1429-1435.
58. Rubia MV, Gandía F, Duque JL. Evaluación de la compliancia vascular pulmonar mediante prueba de esfuerzo con dobutamina en pacientes candidatos a resecciones pulmonares amplias. Arch Bronconeumol 1997; 33: 235-239.
59. Leitch AG, Hopkin JM, Ellis DA, Merchant S, McHardy GJR. The effect of aerosol ipratropium bromide and salbutamol on exercise tolerance in chronic bronchitis. Thorax 1978; 33: 711-713.
60. Teramoto S, Fukuchi Y, Orimo H. Effects of inhaled anticholinergic drug on dyspnea and gas exchange during exercise in patients with chronic obstructive pulmonary disease. Chest 1993; 103: 1774-1782.
61. Ikeda A, Nishimura K, Koyama H, Sugiura N, Izumi T. Oxitropium bromide improves exercise performance in patients with COPD. Chest 1994; 106: 1740-1745.
62. Fink G, Kaye C, Sulkes J, Gabbay U, Spitzer SA. Effect of theophylline on exercise performance in patients with severe chronic obstructive pulmonary disease. Thorax 1994; 49: 332-334.
63. Barberà JA, Roger N, Roca J, Rovira I, Higenbottam TW, Rodríguez-Roisín R. Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease. Lancet 1996; 347: 436-440.
64. Roger N, Barberà JA, Roca J, Rovira I, Gómez FP, Rodríguez-Roisín R. Nitric oxide inhalation during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156: 800-806.
65. Ribas J, Barberà JA, Xaubet A, Mancini M, Sala E, Morera J et al. Efecto del óxido nítrico inhalado durante el ejercicio en pacientes con fibrosis pulmonar idiopática. Arch Bronconeumol 1999; 35 (Supl 2); 102.
66. Montemayor T, Alfajeme I, Escudero C, Morera J, Sanchez Agudo L. Normativa sobre diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica. Arch Bronconeumol 1996; 32: 285-301.
67. Celli BR, Snider GL, Heffner J, Tiep B, Ziment I, Make B et al. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: 577-5120.
68. Pearson MG, Alderslade R, Allen SC, Apps MCP, Barnes G, Bellamy D et al. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997; 52 (Supl 5): 1-28.
69. Elías MT, Ortega F, Fernández J, Toral J, Sánchez H, Montemayor T. Comparación de un test de paseo de carga progresiva (shutlie walking test) con una prueba de esfuerzo en cicloergómetro en pacientes con EPOC. Arch Bronconeumol 1997; 33: 498-502.
70. Marshall BC, Samuelson WM. Basic therapies in cystic fibrosis: does standard therapy work? Clin Chest Med 1998; 19: 487-504.